114 related articles for article (PubMed ID: 37482844)
1. Clinicopathological Value Of Epidermal Growth Factor Receptor (EGFR) And Ki-67 Expression In Colorectal Adenoma And Adenocarcinoma.
Ahmed Nor EM; Saied EM; Mina SN; Shareef MM; Abdelaziz DM
J Pak Med Assoc; 2023 Apr; 73(Suppl 4)(4):S124-S130. PubMed ID: 37482844
[TBL] [Abstract][Full Text] [Related]
2. Expression of EGF, EGF-receptor, p53, v-erb B and ras p21 in colorectal neoplasms by immunostaining paraffin-embedded tissues.
Hayashi Y; Widjono YW; Ohta K; Hanioka K; Obayashi C; Itoh K; Imai Y; Itoh H
Pathol Int; 1994 Feb; 44(2):124-30. PubMed ID: 7912978
[TBL] [Abstract][Full Text] [Related]
3. Epidermal Growth Factor Receptor Expression of Colorectal Carcinoma in Nigerian Patients.
Lawan AI; Ogunbiyi JO
West Afr J Med; 2020; 37(2):100-105. PubMed ID: 32150626
[TBL] [Abstract][Full Text] [Related]
4. Expression of membranous epidermal growth factor receptor in colorectal adenocarcinoma and its correlation with clinicopathological features.
Mohammadi G; Jamialahmadi K; Lary S; Ghaffarzadegan K
Pak J Biol Sci; 2011 Mar; 14(5):357-62. PubMed ID: 21874828
[TBL] [Abstract][Full Text] [Related]
5. Expression of the tyrosine kinase activity growth factor receptors (EGFR, ERB B2, ERB B3) in colorectal adenocarcinomas and adenomas.
Porebska I; Harlozińska A; Bojarowski T
Tumour Biol; 2000; 21(2):105-15. PubMed ID: 10686540
[TBL] [Abstract][Full Text] [Related]
6. The level of epidermal growth factor receptors expression is correlated with the advancement of colorectal adenoma: validation of a surface biomarker.
Williet N; Petcu CA; Rinaldi L; Cottier M; Del Tedesco E; Clavel L; Dumas O; Jarlot C; Bouarioua N; Roblin X; Peoc'h M; Phelip JM
Oncotarget; 2017 Mar; 8(10):16507-16517. PubMed ID: 28157706
[TBL] [Abstract][Full Text] [Related]
7. Expression of CXCR7 in colorectal adenoma and adenocarcinoma: Correlation with clinicopathological parameters.
Sherif MF; Ismail IM; Ata SMS
Ann Diagn Pathol; 2020 Dec; 49():151621. PubMed ID: 32949893
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expressions of Ki-67, cyclin D1, beta-catenin, cyclooxygenase-2, and epidermal growth factor receptor in human colorectal adenoma: a validation study of tissue microarrays.
Su Y; Shrubsole MJ; Ness RM; Cai Q; Kataoka N; Washington K; Zheng W
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1719-26. PubMed ID: 16985035
[TBL] [Abstract][Full Text] [Related]
9. Expression of epidermal growth factor receptor (EGFR) in colorectal cancer: An immunohistochemical study.
Ben Brahim E; Ayari I; Jouini R; Atafi S; Koubaa W; Elloumi H; Chadli A
Arab J Gastroenterol; 2018 Sep; 19(3):121-124. PubMed ID: 30243897
[TBL] [Abstract][Full Text] [Related]
10. Expression of VEGF, EGFR, and IL-6 in gastric adenomas and adenocarcinomas by endoscopic submucosal dissection.
Lee SA; Choi SR; Jang JS; Lee JH; Roh MH; Kim SO; Kim MC; Kim SJ; Jeong JS
Dig Dis Sci; 2010 Jul; 55(7):1955-63. PubMed ID: 19757047
[TBL] [Abstract][Full Text] [Related]
11. Correlation of epidermal growth factor receptor with morphological features of colorectal advanced adenomas: a pilot correlative case series.
Bansal A; Liu X; McGregor DH; Singh V; Hall S
Am J Med Sci; 2010 Oct; 340(4):296-300. PubMed ID: 20622650
[TBL] [Abstract][Full Text] [Related]
12. Expression of Human Epidermal Growth Factor Receptor (Her 2/neu) and Proliferative Marker Ki-67: Association with Clinicopathological Parameters in Gallbladder Carcinoma.
Pujani M; Makker I; Makker A; Jetley S; Goel MM; Jetley S
Asian Pac J Cancer Prev; 2016; 17(8):3903-9. PubMed ID: 27644637
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor, c-erbB-2 and c-erbB-3 expression in colorectal adenoma and adenocarcinoma.
Uner A; Ebinc FA; Akyurek N; Unsal D; Mentes BB; Dursun A
Exp Oncol; 2005 Sep; 27(3):225-8. PubMed ID: 16244586
[TBL] [Abstract][Full Text] [Related]
14. Expression of growth factors and their receptors in human early colorectal carcinomas: immunohistochemical study.
Shirai H; Ueno E; Osaki M; Tatebe S; Ito H; Kaibara N
Anticancer Res; 1995; 15(6B):2889-94. PubMed ID: 8669884
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of pericryptal fibroblast sheath and proliferating epithelial cells in human colorectal adenomas and carcinomas with adenoma components.
Li A; Hasui K; Yonezawa S; Tanaka S; Sato E
Pathol Int; 1999 May; 49(5):426-34. PubMed ID: 10417686
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of matrix metalloproteinase-7 in human colorectal adenomas using specified automated cellular image analysis system: a clinicopathological study.
Qasim BJ; Ali HH; Hussein AG
Saudi J Gastroenterol; 2013; 19(1):23-7. PubMed ID: 23319034
[TBL] [Abstract][Full Text] [Related]
17. Discordance between EGFR expression and clinicopathologic parameters of colorectal adenocarcinoma in Taiwan.
Tsai WC; Lin CK; Lee HS; Chen A; Nieh S; Yu CP; Wu CC; Jao SW; Jin JS
Chin J Physiol; 2012 Oct; 55(5):352-60. PubMed ID: 23282210
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of RelA/nuclear factor-kappa B protein correlates with colorectal tumorigenesis.
Yu HG; Yu LL; Yang Y; Luo HS; Yu JP; Meier JJ; Schrader H; Bastian A; Schmidt WE; Schmitz F
Oncology; 2003; 65(1):37-45. PubMed ID: 12837981
[TBL] [Abstract][Full Text] [Related]
19. Expression and clinicopathologic significance of TUFM and p53 for the normal-adenoma-carcinoma sequence in colorectal epithelia.
Xi HQ; Zhang KC; Li JY; Cui JX; Zhao P; Chen L
World J Surg Oncol; 2017 Apr; 15(1):90. PubMed ID: 28449687
[TBL] [Abstract][Full Text] [Related]
20. An immunohistochemical study of Ki-67 in colorectal adenoma.
Radovanovic-Dinic B; Nagorni A; Katic V; Stamenkovic I; Zlatic A
Med Arh; 2009; 63(1):16-8. PubMed ID: 19419120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
